Description

Glimepirid-TEVA Tablets 4 mg. №30

Ingredients:

Each tablet contains 4 mg of Glimepiride.

Dosage:

The recommended dosage is determined by a healthcare provider based on individual needs.

Indications:

Glimepirid-TEVA tablets are indicated for the treatment of type 2 diabetes mellitus.

Contraindications:

Do not use Glimepirid-TEVA tablets in cases of hypersensitivity to sulfonylureas.

Directions:

Take Glimepirid-TEVA tablets as prescribed by your healthcare provider, usually once daily with a meal.

Scientific Evidence:

Studies have shown that Glimepiride, the active ingredient in Glimepirid-TEVA tablets, effectively lowers blood sugar levels by stimulating the release of insulin from pancreatic beta cells. This mechanism of action helps control glucose levels in patients with type 2 diabetes.

Additional Information:

It is important to monitor blood sugar levels regularly while taking Glimepirid-TEVA tablets to ensure optimal control of diabetes. In case of any unusual symptoms or side effects, consult a healthcare professional immediately.

Glimepirid-TEVA tablets have been subject to clinical trials that have demonstrated their efficacy and safety in the management of type 2 diabetes. These trials have shown significant improvements in glycemic control and overall patient outcomes.